Biocon Biologics ties-up with Sandoz Australia for cancer biosimilars
Sandoz will get the exclusive rights to promote, sell, and distribute Trastuzumab and Bevacizumab, which are used in the treatment of various cancers, in Australia
Matt Erick National Stock Exchange Biocon Ltd Biocon Biologics Ltd Biologics Ltd Chief Commercial Officer
Source: moneycontrol.com